Ebola Virus
Ebola Virus - Related Videos
10:11
Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
0 Views •
Cited by 51 •
2014
Work with infectious Ebola viruses is restricted to biosafety level 4 laboratories. Tetracistronic minigenome-containing replication and transcription-competent virus like particles (trVLPs) represent a lifecycle modeling system that allows us to safely model multiple infectious cycles under biosafety level 2 conditions, relying exclusively on Ebola virus components.
03:08
Production of Reporter-Containing Ebola Virus Transcription- and Replication-Competent Virus-Like Particles
0 Views •
2026
Source: Hoenen, T., et al. Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes. J. Vis. Exp. (2014)This video demonstrates how a tetracistronic minigenome plasmid mimicking the Ebola virus genome is transfected into human cells along with helper plasmids. Inside the cells, viral proteins and luciferase are expressed, leading to the assembly and budding of non-pathogenic, replication-competent virus-like...
09:36
Unbiased Deep Sequencing of RNA Viruses from Clinical Samples
0 Views •
Cited by 46 •
2016
This protocol describes a rapid and broadly applicable method for unbiased RNA-sequencing of viral samples from human clinical isolates.
07:35
Rescue and Characterization of Recombinant Virus from a New World Zika Virus Infectious Clone
0 Views •
Cited by 13 •
2017
This protocol describes the recovery of infectious Zika virus from a two-plasmid infectious cDNA clone.
18:10
Isolation of Fidelity Variants of RNA Viruses and Characterization of Virus Mutation Frequency
0 Views •
Cited by 40 •
2011
The present article describes the steps required to isolate and characterize RNA polymerase fidelity variants of RNA viruses and how to use mutation frequency data to confirm fidelity changes in tissue culture.
FAQs
Surface-receptor interactions determine whether Ebola virus can enter a susceptible cell. After attachment and entry, the virus releases its RNA genome into the cytoplasm, where infection proceeds using viral proteins and host cellular machinery. These early events are important targets for studying host-pathogen interactions and for developing approaches that could limit infection at the cellular level.
Once released into the cytoplasm, the viral RNA genome directs activity involving viral proteins and host machinery to produce new virions. This dependence on both viral and cellular components makes replication a useful focus for biological research. Understanding these steps supports investigations of antiviral therapies designed to interfere with viral reproduction.
Ebola virus infection can disrupt immune regulation and vascular function, linking molecular infection to severe disease effects. Examining these disruptions helps biologists connect viral replication and host responses with disease progression. This perspective supports research on host-pathogen interactions and informs efforts to improve medical responses to Ebola disease.
Molecular diagnostics provide a research and public-health approach for detecting Ebola virus during investigations of suspected outbreaks. Their importance extends beyond identifying infection: timely detection helps characterize an emerging situation and supports outbreak control. Studying diagnostic strategies also strengthens understanding of how viral biology can be translated into practical surveillance and response tools.
Antiviral therapies and vaccines represent complementary strategies in Ebola virus research. Antiviral work focuses on therapeutic intervention, whereas vaccine development aims to support prevention before or around exposure. Together, these areas connect molecular studies of viral replication and host interactions with medical goals for reducing the consequences of Ebola disease.
Biosafety practices are essential because Ebola virus is a high-consequence infectious agent requiring careful handling during research. Appropriate biosafety supports work on replication, diagnostics, therapies, and vaccines while reducing risks associated with laboratory activities. These practices also contribute to broader outbreak preparedness by linking scientific investigation with responsible public-health protection.